Clinical Trials Insight: 700057674
Latest Information Update: 15 Jul 2010
At a glance
- Drugs PSN 821 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors OSI Pharmaceuticals
Most Recent Events
- 03 Dec 2009 New trial record.